Protein Design and Engineering Market Updated Research Report 2024-2031

The Protein Design and Engineering Market Size is valued at USD 5.47 Bn in 2023 and is predicted to reach USD 14.69 Bn by the year 2031 at a 13.39% CAGR during the forecast period for 2024-2031.

protein design

The Protein engineering and designing techniques are used to identify specific amino acid sequence changes and alter this sequence for desired functional properties. Mainly computational simulation methods and experimental/molecular methods are utilized for protein engineering.

Major factors such as increasing government initiatives & funding for the development of protein designing systems, fast advancements in technologies are primarily driving the market growth. High prevalence of protein-deficient diseases, and the surging demand for protein engineering tools by biopharmaceutical companies is also expected to support the market growth. The increasing collaborations between companies operating in this market to develop new testing technologies and accelerate the resource-intensive process of protein engineering are enhancing the growth opportunities of the protein design and engineering market. For instance, in January 2021, Zymvol Biomodeling (Spain) collaborated with Aminoverse, a biotech company specializing in enzyme discovery and design, to develop custom-made alcohol dehydrogenases, an enzyme most commonly used in the flavors and fragrances and the fine chemicals industry.

However, the expensive instruments and the increasing maintenance cost of the protein engineering equipment may hinder the market growth during the estimated timeframe.

Market Segmentation

The Protein design and engineering market is segmented into the protein engineering approach used, protein types, type of application, end-users, and region. The protein engineering approach used segment comprises rational designing, directed evolution, and semi-rational designing. The rational designing segment is estimated to dominate this market during the forecast period due to its rising use in antibody and enzyme designing. The market is classified into antibodies, peptides, enzymes, vaccines, and others based on the protein types. The antibodies are expected to be the fastest-growing segment of this market, owing to their increasing applications in the medical sector. The market is grouped into therapeutics and diagnostics by type of application. The market is segmented into pharma/biotech firms, CROs (contract research organizations) & research, and academic institutes by end-users. The pharma/biotech firms are projected to hold a significant market share in the coming years due to the rising demand for advanced drug and therapy treatments to cure chronic diseases. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The Asia-Pacific market is likely to witness rapid growth during the forecast period (2019-2030) due to the well-established healthcare infrastructure, growing awareness regarding protein engineering, and the rising government efforts to develop protein designing methods.

Protein Design and Engineering Market Report Scope

Report Attribute	Specifications
Market Size Value In 2023	USD 5.47 Bn
Revenue Forecast In 2031	USD 14.69 Bn
Growth Rate CAGR	CAGR of 13.39% from 2024 to 2031
Quantitative Units	Representation of revenue in US$ Bn, and CAGR from 2024 to 2031
Historic Year	2019 to 2023
Forecast Year	2024-2031
Report Coverage	The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered	By Protein Engineering Approach Used, Protein Types, Type Of Application, End-users
Regional Scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope	U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea
Competitive Landscape	ATUM (US), Creative BioMart (US), Creative Biostructure (US), Creative Enzymes (US), Absolute Antibody (UK), EUCODIS Bioscience (Austria), Fusion Antibodies (UK), Innovagen (Sweden), ZYMVOL (Spain), Averring Biotech, EnzymeWorks (China), GeNext Genomics (India), Quantumzyme (India), and others.
Customization Scope	Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods	Explore pricing alternatives that are customized to your specific requirements.